Skip to main content

FLOTEK INDUSTRIES INC/CN/

For the period ended Mar 31, 2026. Filed May 7, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 7, 2026

FTK$25.98+6.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

PART II

FLOTEK INDUSTRIES INC.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share data)

March 31, 2026December 31, 2025
ASSETS
Current assets:
Cash and cash equivalents$5,676$5,731
Restricted cash104104
Accounts receivable, net of allowance for credit losses of $820 and $764 at March 31, 2026 and December 31, 2025, respectively21,79419,043
Accounts receivable, related party, net of allowance for credit losses of $0 at March 31, 2026 and December 31, 202561,02364,204
Equipment credit, related party11,782—
Inventories, net14,30310,629
Other current assets2,7093,445
Current contract asset8,4027,621
Total current assets125,793110,777
Long-term contract asset52,10255,115
Property and equipment, net21,91220,344
Right-of-use assets2,8953,083
Deferred tax assets, net27,58029,152
Other long-term assets1,5611,578
TOTAL ASSETS$231,843$220,049
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$52,566$48,317
Accrued liabilities8,7717,256
Income taxes payable295258
Interest payable, related party9861,008
Current portion of operating lease liabilities1,2871,251
Current portion of finance lease liabilities156153
Asset-based loan4,6663,332
Total current liabilities68,72761,575
Note payable - related party, net of deferred financing costs39,60839,584
Long-term operating lease liabilities5,1495,608
Long-term finance lease liabilities184224
TOTAL LIABILITIES113,668106,991
Stockholders’ equity:
Preferred stock, $0.0001 par value, 100,000 shares authorized; no shares issued and outstanding——
Common stock, $0.0001 par value, 240,000,000 shares authorized; 37,390,332 shares issued and 36,174,338 shares outstanding at March 31, 2026; 31,320,960 shares issued and 30,130,480 shares outstanding at December 31, 202543
Additional paid-in capital435,838434,964
Accumulated other comprehensive income13096
Accumulated deficit(281,116)(285,780)
Treasury stock, at cost; 1,215,994 and 1,190,480 shares at March 31, 2026 and December 31, 2025, respectively(36,681)(36,225)
Total stockholders’ equity118,175113,058
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY$231,843$220,049

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

Three Months Ended March 31,
20262025
Revenue:
Revenue from external customers$18,165$24,423
Revenue from related party51,88630,939
Total revenues70,05155,362
Cost of sales54,51042,913
Gross profit15,54112,449
Operating costs and expenses:
Selling, general, and administrative6,9256,282
Depreciation631252
Research and development396355
Gain on sale of property and equipment—(7)
Total operating costs and expenses7,9526,882
Income from operations7,5895,567
Other expense:
Interest expense(1,332)(229)
Other income, net16106
Total other expense(1,316)(123)
Income before income taxes6,2735,444
Income tax expense(1,609)(64)
Net income$4,664$5,380
Income per common share:
Basic$0.13$0.18
Diluted$0.12$0.17
Weighted average common shares:
Weighted average common shares used in computing basic income per common share36,10029,683
Weighted average common shares used in computing diluted income per common share38,34031,752

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

Three months ended March 31,
20262025
Net income$4,664$5,380
Other comprehensive income:
Foreign currency translation adjustment34(45)
Comprehensive income$4,698$5,335

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

Three months ended March 31,
20262025
Cash flows from operating activities:
Net income$4,664$5,380
Adjustments to reconcile net income to net cash provided by operating activities:
Change in fair value of contingent consideration—(125)
Amortization of contract assets2,2321,482
Depreciation631252
Amortization of deferred financing costs9571
Provision for credit losses, net of recoveries5666
Provision for excess and obsolete inventory39664
Gain on sale of property and equipment—(7)
Non-cash lease expense188318
Stock compensation expense824461
Deferred income tax expense1,57214
Changes in current assets and liabilities:
Accounts receivable(2,808)(2,489)
Accounts receivable, related party(9,798)4,124
Inventories(4,070)(354)
Income tax receivable20—
Other assets663(540)
Accounts payable4,249893
Accrued liabilities1,515(1,811)
Operating lease liabilities(423)(568)
Income taxes payable3782
Interest payable, related party(22)—
Net cash provided by operating activities217,313
Cash flows from investing activities:
Capital expenditures(1,002)(598)
Proceeds from sale of assets—7
Net cash used in investing activities(1,002)(591)
Cash flows from financing activities:
Payments on long term debt—(45)
Proceeds from asset-based loan55,10053,345
Payments on asset-based loan(53,766)(58,136)
Proceeds from exercise of April 2025 Warrant1—
Payments to tax authorities for shares withheld from employees(456)(23)
Proceeds from issuance of stock under Employee Stock Purchase Plan4431
Proceeds from stock option exercises6—
Payments for finance leases(37)—
Net cash provided by (used in) financing activities892(4,828)
Effect of changes in exchange rates on cash and cash equivalents34(45)
Net change in cash and cash equivalents and restricted cash(55)1,849
Cash and cash equivalents at the beginning of the period5,7314,404
Restricted cash at the beginning of the period104102
Cash and cash equivalents and restricted cash at the beginning of the period5,8354,506
Cash and cash equivalents at the end of the period5,6766,253
Restricted cash at the end of the period104102
Cash and cash equivalents and restricted cash at the end of the period$5,780$6,355

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

Three Months Ended March 31, 2026
Common Stock · Treasury Stock · AdditionalPaid-inCapital · AccumulatedOtherComprehensiveIncome · Accumulated Deficit · Total Stockholders’ Equity
SharesIssued · ParValue · Shares · Cost
Balance, December 31, 202531,32131,190(36,225)$434,964$96$(285,780)$113,058
Net income——————4,6644,664
Foreign currency translation adjustment—————34—34
Stock option exercises2———6——6
Stock issued under employee stock purchase plan——(2)—44——44
Restricted stock granted67———————
Stock compensation expense————824——824
Shares withheld to cover taxes——28(456)———(456)
Exercise of April 2025 Warrant (Note 13)6,0001—————1
Balance, March 31, 202637,390$41,216$(36,681)$435,838$130$(281,116)$118,175
Three Months Ended March 31, 2025
Common Stock · Treasury Stock · AdditionalPaid-inCapital · AccumulatedOtherComprehensiveIncome · Accumulated Deficit · Total Stockholders’ Equity
SharesIssued · ParValue · Shares · Cost
Balance, December 31, 202430,938$31,112$(34,666)$464,620$251$(316,308)$113,900
Net income——————5,3805,380
Foreign currency translation adjustment—————(45)—(45)
Stock issued under employee stock purchase plan——(4)—31——31
Restricted stock forfeited——3—————
Restricted stock vested3———————
Stock compensation expense————461——461
Shares withheld to cover taxes——3(23)———(23)
Balance, March 31, 202530,941$31,114$(34,689)$465,112$206$(310,928)$119,704
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.